Screening for hypertension in children and adolescents to prevent cardiovascular disease

Pediatrics

Volumn 131, Issue 3, 2013, Pages 490-525

  Thompson, Matthew ^a,b   Dana, Tracy ^a   Bougatsos, Christina ^a   Blazina, Ian ^a   Norris, Susan L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adolescents; Children; Drug; Hypertension; Lifestyle; Screening; Treatment

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE; CANDESARTAN; CHLORTALIDONE; EPLERENONE; FELODIPINE; METOPROLOL; PLACEBO; POTASSIUM CHLORIDE; PROPRANOLOL; TELMISARTAN;

ADOLESCENT; ADULTHOOD; ARTERIAL WALL THICKNESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHILD; CHILDHOOD; COCHRANE LIBRARY; COUGHING; DIAGNOSTIC ACCURACY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MEDLINE; NAUSEA; NUTRITION EDUCATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; UNITED STATES; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION;

EID: 84874641700     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-3523     Document Type: Review

References (78)

1. Lurbe E, Álvarez J, Redon J. Diagnosis and treatment of hypertension in children. Curr Hypertens Rep. 2010;12(6):480-486
2. Obarzanek E, Wu CO, Cutler JA, Kavey RE, Pearson GD, Daniels SR. Prevalence and incidence of hypertension in adolescent girls. J Pediatr. 2010;157(3):461-467, 467, e1-e5
3. Din-Dzietham R, Liu Y, Bielo M-V, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116(13):1488-1496
4. Flynn JT, Falkner BE. The importance of blood pressure screening in children. J Pediatr. 2009;155(2):299-300, author reply 299-300
5. Brady TM, Solomon BS, Neu AM, Siberry GK, Parekh RS. Patient-, provider-, and cliniclevel predictors of unrecognized elevated blood pressure in children. Pediatrics. 2010;125(6). Available at: www.pediatrics. org/cgi/content/full/ 125/6/e1286
6. Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298(8):874-879
7. Sun SS, Grave GD, Siervogel RM, Pickoff AA, Arslanian SS, Daniels SR. Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics. 2007;119(2):237-246
8. Rosner B, Cook N, Portman R, Daniels S, Falkner B. Blood pressure differences by ethnic group among United States children and adolescents. Hypertension. 2009;54(3): 502-508
9. Falkner B, Gidding SS, Ramirez-Garnica G, Wiltrout SA, West D, Rappaport EB. The relationship of body mass index and blood pressure in primary care pediatric patients. J Pediatr. 2006;148(2):195-200
10. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 2004;113(3 pt 1):475-482
11. Moore WE, Eichner JE, Cohn EM, Thompson DM, Kobza CE, Abbott KE. Blood pressure screening of school children in a multiracial school district: the Healthy Kids Project. Am J Hypertens. 2009;22(4):351-356
12. Chiolero A, Cachat F, Burnier M, Paccaud F, Bovet P. Prevalence of hypertension in schoolchildren based on repeated measurements and association with overweight. J Hypertens. 2007;25(11):2209-2217
13. Liao CC, Su TC, Chien KL, et al. Elevated blood pressure, obesity, and hyperlipidemia. J Pediatr. 2009;155(1):79-83, 83, e1
14. Jago R, Harrell JS, McMurray RG, Edelstein S, El Ghormli L, Bassin S. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics. 2006;117(6):2065-2073
15. Centers for Disease Control and Prevention. Overweight and obesity: data and statistics. Available at: www.cdc.gov/obesity/childhood/data.html. Accessed December 3, 2012
16. Friedemann C, Heneghan C, Mahtani K, Thompson M, Perera R, Ward AM. Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. BMJ. 2012;345:e4759
17. Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents. JAMA. 2004;291(17):2107-2113
18. Jung FF, Ingelfinger JR. Hypertension in childhood and adolescence. Pediatr Rev. 1993;14(5):169-179
19. Hohn AR, Dwyer KM, Dwyer JH. Blood pressure in youth from four ethnic groups: the Pasadena Prevention Project. J Pediatr. 1994;125(3):368-373
20. Flynn JT. Evaluation and management of hypertension in childhood. Prog Pediatr Cardiol. 2001;12(2):177-188
21. Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. Am Fam Physician. 2010;82(12): 1471-1478
22. Srinivasan SR, Myers L, Berenson GS. Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart Study. Hypertension. 2006;48(1):33-39
23. Rademacher ER, Jacobs DR Jr, Moran A, Steinberger J, Prineas RJ, Sinaiko A. Relation of blood pressure and body mass index during childhood to cardiovascular risk factor levels in young adults. J Hypertens. 2009;27(9):1766-1774
24. US Preventive Services Task Force. Guide to Clinical Preventive Services: Periodic Updates. 3rd ed. Rockville, MD: Agency for Healthcare Research and Quality; 2003
25. Thompson M, Bougatsos C, Dana T, Blazina I, Norris S. Screening for Hypertension in Children and Adolescents to Prevent Cardiovascular Disease: Systematic Review for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality
26. Harris RP, Helfand M, Woolf SH, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 suppl):21-35
27. US Preventive Services Task Force. Procedure manual: section 4 evidence report development. Available at: www.uspreventiveservicestaskforce. org/uspstf08/methods/procmanual4.htm. Accessed December 3, 2012
28. Whitlock EP, O'Connor EA, Williams SB, Beil TL, Lutz KW. Effectiveness of weight management interventions in children: a targeted systematic review for the USPSTF. Pediatrics. 2010;125(2). Available at: www.pediatrics.org/cgi/ content/full/125/2/e396
29. Haney EM, Huffman LH, Bougatsos C, Freeman M, Steiner RD, Nelson HD. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2007;120(1). Available at: www.pediatrics.org/cgi/content/full/120/ 1/e189
30. Fixler DE, Laird WP. Validity of mass blood pressure screening in children. Pediatrics. 1983;72(4):459-463
31. Stergiou GS, Nasothimiou E, Giovas P, Kapoyiannis A, Vazeou A. Diagnosis of hypertension in children and adolescents based on home versus ambulatory blood pressure monitoring. J Hypertens. 2008;26 (8):1556-1562
32. Berenson GS, Dalferes E Jr, Savage D, Webber LS, Bao W. Ambulatory blood pressure measurements in children and young adults selected by high and low casual blood pressure levels and parental history of hypertension: the Bogalusa Heart Study. Am J Med Sci. 1993;305(6): 374-382
33. Ewart CK, Harris WL, Iwata MM, Coates TJ, Bullock R, Simon B. Feasibility and effectiveness of school-based relaxation in lowering blood pressure. Health Psychol. 1987;6(5):399-416
34. Fixler DE, Laird WP, Fitzgerald V, Stead S, Adams R. Hypertension screening in schools: results of the Dallas study. Pediatrics. 1979;63(1):32-36
35. Kelsall JE, Watson AR. Should school nurses measure blood pressure? Public Health. 1990;104(3):191-194
36. Michaud PA. Adolescent hypertension: a follow-up study in the community. Rev Epidemiol Sante Publique. 1989;37(1):23-28
37. Miller FS III, Record NB Jr. Hypertension control in rural Maine. Franklin County high blood pressure program. J Maine Med Assoc. 1976;67(9):280-283
38. Rames LK, Clarke WR, Connor WE, Reiter MA, Lauer RM. Normal blood pressure and the evaluation of sustained blood pressure elevation in childhood: the Muscatine study. Pediatrics. 1978;61(2):245-251
39. Reichman LB, Cooper BM, Blumenthal S, et al. Hypertension testing among high school students. I. Surveillance procedures and results. J Chronic Dis. 1975;28(3):161-171
40. Sailors EL. Project "hypertension alert". J Sch Health. 1983;53(6):374-376
41. Sinaiko AR, Gomez-Marin O, Prineas RJ. "Significant" diastolic hypertension in prehigh school black and white children. The children and adolescent blood pressure program. Am J Hypertens. 1988;1(2):178-180
42. Stern B, Heyden S, Miller D, Latham G, Klimas A, Pilkington K. Intervention study in high school students with elevated blood pressures. Dietary experiment with polyunsaturated fatty acids. Nutr Metab. 1980;24(3):137-147
43. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens. 1995;8(7):657-665
44. Beckett LA, Rosner B, Roche AF, Guo S. Serial changes in blood pressure from adolescence into adulthood. Am J Epidemiol. 1992;135(10):1166-1177
45. Gillman MW, Cook NR, Rosner B, et al. Identifying children at high risk for the development of essential hypertension. J Pediatr. 1993;122(6):837-846
46. Hoq S, Chen W, Srinivasan SR, Berenson GS. Childhood blood pressure predicts adult microalbuminuria in African Americans, but not in whites: the Bogalusa Heart Study. Am J Hypertens. 2002;15(12):1036-1041
47. Juhola J, Magnussen CG, Viikari JSA, et al. Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study. J Pediatr. 2011;159(4): 584-590
48. Lauer RM, Clarke WR, Mahoney LT, Witt J. Childhood predictors for high adult blood pressure. The Muscatine Study. Pediatr Clin North Am. 1993;40(1):23-40
49. Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003;290 (17):2271-2276
50. Raitakari OT, Juonala M, Kähönen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290(17): 2277-2283
51. Shear CL, Burke GL, Freedman DS, Webber LS, Berenson GS. Designation of children with high blood pressure-considerations on percentile cut points and subsequent high blood pressure: the Bogalusa Heart Study. Am J Epidemiol. 1987;125(1):73-84
52. Stenn PG, Noce A, Buck C. A study of the labelling phenomenon in school children with elevated blood pressure. Clin Invest Med. 1981;4(3-4):179-181
53. Batisky DL, Sorof JM, Sugg J, et al; Toprol-XL Pediatric Hypertension Investigators. Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience. J Pediatr. 2007;150(2):134-139, 139, e1
54. Flynn JT, Newburger JW, Daniels SR, et al; PATH-1 Investigators. A randomized, placebocontrolled trial of amlodipine in children with hypertension. J Pediatr. 2004;145(3): 353-359
55. Li JS, Flynn JT, Portman R, et al. The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: a randomized, double-blind, doseresponse study. J Pediatr. 2010;157(2):282-287
56. Sorof JM, Cargo P, Graepel J, et al. Betablocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial. Pediatr Nephrol. 2002;17(5):345-350
57. Trachtman H, Frank R, Mahan JD, et al. Clinical trial of extended-release felodipine in pediatric essential hypertension. Pediatr Nephrol. 2003;18(6):548-553
58. Trachtman H, Hainer JW, Sugg J, Teng R, Sorof JM, Radcliffe J; Candesartan in Children with Hypertension (CINCH) Investigators. Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years. J Clin Hypertens (Greenwich). 2008;10(10): 743-750
59. Wells TG, Portman R, Norman P, Haertter S, Davidai G, Fei Wang. Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension. Clin Pediatr (Phila). 2010;49(10):938-946
60. Berenson GS, Voors AW, Webber LS, et al. A model of intervention for prevention of early essential hypertension in the 1980s. Hypertension. 1983;5(1):41-54
61. Berenson GS, Shear CL, Chiang YK, Webber LS, Voors AW. Combined low-dose medication and primary intervention over a 30-month period for sustained high blood pressure in childhood. Am J Med Sci. 1990;299(2):79-86
62. Couch SC, Saelens BE, Levin L, Dart K, Falciglia G, Daniels SR. The efficacy of a clinicbased behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure. J Pediatr. 2008;152(4):494-501
63. Gregoski MJ, Barnes VA, Tingen MS, Harshfield GA, Treiber FA. Breathing awareness meditation and LifeSkills Training programs influence upon ambulatory blood pressure and sodium excretion among African American adolescents. J Adolesc Health. 2011;48(1):59-64
64. Hansen HS, Froberg K, Hyldebrandt N, Nielsen JR. A controlled study of eight months of physical training and reduction of blood pressure in children: the Odense schoolchild study. BMJ. 1991;303(6804): 682-685
65. Howe PR, Cobiac L, Smith RM. Lack of effect of short-term changes in sodium intake on blood pressure in adolescent schoolchildren. J Hypertens. 1991;9(2):181-186
66. Sinaiko AR, Gomez-Marin O, Prineas RJ. Effect of low sodium diet or potassium supplementation on adolescent blood pressure. Hypertension. 1993;21(6 pt 2):989-994
67. Hazan L, Hernández Rodriguez OA, Bhorat AE, Miyazaki K, Tao B, Heyrman R; Assessment of Efficacy and Safety of Olmesartan in Pediatric Hypertension Study Group. A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension. Hypertension. 2010;55(6):1323-1330
68. Li JS, Berezny K, Kilaru R, et al. Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children? Hypertension. 2004;44(3):289-293
69. Shahinfar S, Cano F, Soffer BA, et al. A double-blind, dose-response study of losartan in hypertensive children. Am J Hypertens. 2005;18(2 pt 1):183-190
70. Soffer B, Zhang Z, Miller K, Vogt BA, Shahinfar S. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens. 2003;16(10): 795-800
71. Wells T, Frame V, Soffer B, et al; Enalapril Pediatric Hypertension Collaborative Study Group. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol. 2002;42(8): 870-880
72. Smith PB, Li JS, Murphy MD, Califf RM, Benjamin DK Jr. Safety of placebo controls in pediatric hypertension trials. Hypertension. 2008;51(4):829-833
73. Baker-Smith CM, Benjamin DK Jr, Califf RM, Murphy MD, Li JS, Smith PB. Cough in pediatric patients receiving angiotensinconverting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials. Clin Pharmacol Ther. 2010;87(6):668-671
74. Chen X, Wang Y, Appel LJ, Mi J. Impacts of measurement protocols on blood pressure tracking from childhood into adulthood: a metaregression analysis. Hypertension. 2008;51(3):642-649
75. Tirosh A, Afek A, Rudich A, et al. Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension. 2010;56(2):203-209
76. Batisky DL. Obesity and the role of lifestyle and dietary intervention in the management of pediatric hypertension. J Med Liban. 2010;58(3):171-174
77. Juonala M, Viikari JSA, Hutri-Kähönen N, et al. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference. J Intern Med. 2004;255(4):457-468
78. Frank GC, Farris RP, Ditmarsen P, Voors AW, Berenson GS. An approach to primary preventive treatment for children with high blood pressure in a total community. J Am Coll Nutr. 1982;1(4):357-374